Open AccessPropofol infusion Syndrome
Author(s) -
S. Shakir Hasan
Publication year - 2020
Publication title -
anaesthesia, pain and intensive care
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.17
H-Index - 8
eISSN - 2220-5799
pISSN - 1607-8322
DOI - 10.35975/apic.v24i2.1265
Subject(s) - propofol , medicine , anesthesia , intensive care unit , adverse effect , intensive care medicine , intensive care , population , paediatric intensive care unit , pediatrics , environmental health
I am writing in order to stress upon the correct and safe rate of propofol infusion in intensive care unit (ICU) as a high rate of infusion can easily be missed and can lead to serious consequences. Propofol infusion syndrome (PRIS) is a well-known entity, which has been reported in both children and adults and is related to its high rates. First death due to PRIS was reported in 1990. The term was originally coined in 1998 by Bray to describe the adverse effects with its use in pediatric population. Though the first case was reported in a child, it has now been increasingly reported in adult ICU patients too.